Radiology departments play an important role in helping doctors diagnose and plan care for patients. Adding AI into radiology workflows aims to make diagnoses more accurate, lower the amount of work needed, and save time. Still, hospitals worry about the costs at first and want to see if the benefits are worth it.
A recent study funded by Bayer AG created and tested an ROI calculator focused on AI tools used in radiology diagnosis. The tool was built using data from expert interviews and many studies. It compared costs, revenue, and patient outcomes with and without AI over five years.
The main goal was to give hospital leaders a useful tool to check both the money and health results of using AI. It also looked at different types of hospitals and ways they operate.
The study showed important savings in work time and positive financial returns after adding AI to radiology departments. Over five years, the AI system gave a 451% ROI. When adding in the time saved by radiologists, the ROI rose to 791%. This means every $1 spent could bring back up to $7.91 after counting time savings.
These savings show AI can cut down the workload on radiologists. This helps hospitals handle more imaging tests, especially in places focused on stroke care.
Besides saving on labor costs, the AI platform found patients who needed extra scans, hospital stays, or treatment. Finding these patients caused more treatments to happen, which was the biggest factor in increased ROI. Hospitals made more money by treating patients earlier than they might have otherwise.
The ROI results also changed based on hospital type and how long the study looked at. Stroke care hospitals, which have more complex and many imaging tests, saw bigger returns than smaller centers without such specialization.
The ROI calculator helps users test different hospital types, timespans, and numbers of scans. U.S. medical leaders can use it to compare situations that match their own organizations.
Using this tool highlights some often missed points:
Healthcare leaders can use these ideas to focus on AI investments based on the hospital’s kind, patient needs, and types of testing. This helps them feel sure that the technology adds value.
One main reason AI returns good value is that it can automate and speed up tasks in radiology departments.
AI systems can sort scans, do quick first reads, and spot urgent cases so radiologists can check those faster. This cuts wait times for patients and speeds up medical decisions. The study found radiologists saved over 15 full workdays just from shorter waiting times.
AI helps radiologists spend less time deciding scan priority and more time on hard cases. With 78 fewer days spent on triage, radiologists can focus on work that needs more skill. This can reduce burnout and help job satisfaction.
During report writing, AI can start first drafts or pull out key data, cutting down about 41 days. Faster reports mean doctors get results sooner, which helps patients get timely treatment.
AI tools learn from big amounts of data to find patterns human eyes might miss. This leads to better detection of problems, fewer mistakes, and better senses of who needs follow-up care. This boost in detecting needed treatments added to hospital earnings.
AI systems can be quickly updated and changed, like fraud detection AI in places like PayPal. This helps healthcare AI stay accurate and follow new rules or data changes. Being able to change AI fast lets radiology departments keep AI useful over time as patient and legal needs evolve.
Measuring AI’s ROI in healthcare is tricky and goes beyond just money numbers. Both clear money gains and less obvious benefits are important.
Hospital leaders and IT managers in the U.S. need to know both sides to make smart choices. Without this, investments might seem unprofitable even if care gets better or staff feel better.
Main challenges include:
To deal with these, answers include:
This way, health leaders get better information to balance money and clinical results when making decisions.
Hospitals and clinics in the U.S. face strong competition and many rules. Choosing new technology means thinking about patient results, staff load, and money health.
Using AI in radiology, as shown by the ROI calculator study, gives a clear option to improve many parts of hospital work.
Healthcare managers can use these results to:
Also, by using ROI-based checks, decision makers reduce the risk that AI fails to deliver results and make sure AI meets hospital goals.
Using these data and tools, hospital managers, practice owners, and IT staff in the U.S. can better handle AI’s growing role in radiology. They can make sure investments give good health results and money value.
The study aimed to develop a comprehensive return on investment (ROI) calculator to evaluate both monetary and nonmonetary benefits of an AI-powered radiology diagnostic imaging platform for decision-makers considering AI adoption in hospitals.
The calculator was constructed using comparative costs, estimated revenues, and clinical values of AI in radiology workflows, determined through expert interviews and literature review, along with scenario and deterministic sensitivity analyses.
The introduction of the AI platform yielded an ROI of 451% over five years, which increased to 791% when accounting for time savings of radiologists.
The AI platform facilitated significant labor time reductions, equating to more than 15 eight-hour working days in waiting time, 78 days in triage, 10 days in reading, and 41 days in reporting.
The use of the AI platform generated revenue benefits by attracting patients for clinically beneficial follow-up scans, hospitalizations, and treatment procedures.
The ROI calculations were sensitive to time horizons, health center settings, and the number of scans performed, with the most significant outcome being the number of additional treatments prompted by AI.
AI identification of patients led to additional necessary treatments, which was the most influential factor in determining ROI.
The ROI calculator serves as a useful tool for evaluating the financial and clinical benefits of AI-powered radiology platforms, aiding healthcare decision-makers in understanding the investments necessary for adoption.
The authors Prateek Bharadwaj, Franziska Lobig, and Michael Blankenburg are affiliated with Bayer AG, while other authors reported consulting or advisory relationships with Bayer.
The study evaluated the impact of the AI platform specifically within a hospital accredited for stroke management, indicating a focused application of AI in a critical healthcare domain.